NCPI Workmark
Articles in regional publications that pertain to a wide range of North Carolina-related topics.

Search Results


4 results for AIDS (Disease) vaccines
Currently viewing results 1 - 4
PAGE OF 1
Record #:
1430
Author(s):
Abstract:
According to Fred Gregg, senior manager for HIV community relations at Research Triangle Park-based Burroughs Wellcome Company, the HIV epidemic has increasingly caused pharmaceutical companies to consider the consumer, like the physician, as a customer.
Source:
North Carolina (NoCar F 251 W4), Vol. 52 Issue 2, Feb 1994, p58, il, por
Record #:
25870
Author(s):
Abstract:
Microbiologist Bob Johnston and others are working on new approaches to HIV prevention. They aim to find vectored vaccines that could provide immunization against HIV, and herbs that naturally disrupt virus replication.
Source:
Endeavors (NoCar LD 3941.3 A3), Vol. 23 Issue 2, Winter 2007, p38-41, il, por Periodical Website
Full Text:
Record #:
26978
Author(s):
Abstract:
Burroughs Wellcome Company discovered that the drug AZT can prolong the lives of many people with AIDS, but at an annual cost of about ten-thousand dollars per patient. North Carolina has a share of the federal safety-net program to help AIDS patients who can’t afford AZT. Others who are without federal aid are organizing boycotts against Burroughs and considering lawsuits.
Source:
Independent Weekly (NoCar Oversize AP 2 .I57 [volumes 13 - 23 on microfilm]), Vol. 6 Issue 7, Apr 7-20 1988, p7, il Periodical Website
Record #:
38209
Author(s):
Abstract:
Imagining the end of HIV includes the reality of overcoming challenges related to making the end possible. Challenges Charlotte-based organizations like RAIN address are accessing medications; the complicated treatment of HIV; Mecklenburg County’s HIV cases rate, among the highest in the nation.